Deerfield Management: €5M-€100M checks, Seed to Growth
- Check size
- €5M – €100M
- Outreach
- Apply via form
Investment focus
Sectors
Geographic focus
Global
United States
Investment thesis
New York-based healthcare investment firm with $15B+ AUM. Invests across the lifecycle from early startup to public company in therapeutics, devices, diagnostics, digital health, and healthcare AI.
How to Pitch Deerfield Management
Apply through their form
Deerfield Management prefers applications through their own form, but no link is on file yet. Check their website.
Who to contact
Abraham Kometz
Partner
Medical Technologies
Andrew ElBardissi
Partner
Medical Technologies
Portfolio highlights
BridgeBio Pharma - genetic disease therapeutics (NASDAQ-listed)
SpringWorks Therapeutics - rare disease oncology (NASDAQ-listed)
Nuvalent - precision oncology therapeutics (NASDAQ-listed)
Partners
Auto-detected from Deerfield Management's website.
Terence Fox-Karnal
Partner and Head Equity Linked and Credit Trader
Public Structured Finance
Trading
Checked Sept 2026
Similar investors
Focus and check size from the firm's website. Website reachable as of Nov 2026.
Ready to reach Deerfield Management?
Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.
Contact
deerfield.com
Reach Deerfield Management through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.